Wireby Fusion42
Read this story on the live Wire →

Wire · founder news, decoded · opportunities

Alert Failures, AI Errors, And Hypoglycemic Episodes: FDA Wants Input On Exempt Health Software

The FDA is seeking public input on how to regulate exempt health software, with specific concerns about alert failures, AI errors, and patient safety incidents like hypoglycemic episodes. The agency is attempting to define which software poses genuine risk and therefore should require oversight versus which remains safely exempt.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.

The Wire takeaway

If you build health software that doesn't touch diagnosis or treatment, you've been exempt from FDA oversight—but that door is closing. The agency is now writing rules around AI and alerts, which means your unregulated product will soon need either a compliance pathway or a business model pivot.

Read the full story at insights.citeline.com

Topics: Digital Health · fda-exemption · ai-safety · software-regulation · healthtech-compliance

Related on Wire

Verified 17 July 2026 · Sources: Fusion42 review